Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vo Van Giau, Hyon Lee, Seong Soo A An & John Hulme. (2019) Recent advances in the treatment of C. difficile using biotherapeutic agents. Infection and Drug Resistance 12, pages 1597-1615.
Read now
Read now
Enrico D'Amelio, Simonetta Salemi & Raffaele D'Amelio. (2016) Anti-Infectious Human Vaccination in Historical Perspective. International Reviews of Immunology 35:3, pages 260-290.
Read now
Read now
Harsh Mathur, Mary C Rea, Paul D Cotter, R Paul Ross & Colin Hill. (2014) The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes 5:6, pages 696-710.
Read now
Read now
Articles from other publishers (20)
Davide Lo Porto, Alessandra Mularoni, Elio Castagnola & Carolina Saffioti. (2023) Clostridioides difficile infection in the allogeneic hematopoietic cell transplant recipient. Transplant Infectious Disease 25:S1.
Crossref
Crossref
Parul Berry & Sahil Khanna. (2023) Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies. BioDrugs 37:6, pages 757-773.
Crossref
Crossref
Ana Aleksić, Zorica Stojanović-Radić, Celine Harmanus, Ed J. Kuijper & Predrag Stojanović. (2022) In vitro anti-clostridial action and potential of the spice herbs essential oils to prevent biofilm formation of hypervirulent Clostridioides difficile strains isolated from hospitalized patients with CDI. Anaerobe 76, pages 102604.
Crossref
Crossref
Caixia Tan, Fei Zhu, Yuanyuan Xiao, Yuqi Wu, Xiujuan Meng, Sidi Liu, Ting Liu, Siyao Chen, Juan Zhou, Chunhui Li & Anhua Wu. (2022) Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile. Frontiers in Immunology 13.
Crossref
Crossref
Joanna Giles & April Roberts. 2022. Immunotherapeutics. Immunotherapeutics
215
245
.
Britt Nibbering, Dale N. Gerding, Ed J. Kuijper, Romy D. Zwittink & Wiep Klaas Smits. (2021) Host Immune Responses to Clostridioides difficile: Toxins and Beyond. Frontiers in Microbiology 12.
Crossref
Crossref
Megan G. Taggart, William J. Snelling, Patrick J. Naughton, Roberto M. La Ragione, James S. G. Dooley & Nigel G. Ternan. (2021) Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence. PLOS Pathogens 17:9, pages e1009817.
Crossref
Crossref
Charmaine Normington, Ines B. Moura, Jessica A. Bryant, Duncan J. Ewin, Emma V. Clark, Morgan J. Kettle, Hannah C. Harris, William Spittal, Georgina Davis, Matthew R. Henn, Christopher B. Ford, Mark H. Wilcox & Anthony M. Buckley. (2021) Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. npj Biofilms and Microbiomes 7:1.
Crossref
Crossref
William E. Matchett, Stephanie Anguiano-Zarate, Goda Baddage Rakitha Malewana, Haley Mudrick, Melissa Weldy, Clayton Evert, Alexander Khoruts, Michael Sadowsky & Michael A. Barry. (2020) A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile. Vaccines 8:3, pages 470.
Crossref
Crossref
T.V. Riley, D. Lyras & G.R. Douce. (2019) Status of vaccine research and development for Clostridium difficile. Vaccine 37:50, pages 7300-7306.
Crossref
Crossref
Marjorie Pizarro-Guajardo, Nayaret Chamorro-Veloso, Roberto Mauricio Vidal & Daniel Paredes-Sabja. (2019) New insights for vaccine development against Clostridium difficile infections. Anaerobe 58, pages 73-79.
Crossref
Crossref
Laurence Quemeneur, Nadine Petiot, Nadège Arnaud-Barbe, Catherine Hessler, Patricia J. Pietrobon & Patricia Londoño-Hayes. (2018) Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting. Infection and Immunity 86:6.
Crossref
Crossref
Claudia Vuotto, Gianfranco Donelli, Anthony Buckley & Caroline Chilton. 2018. Updates on Clostridium difficile in Europe. Updates on Clostridium difficile in Europe
97
115
.
Jean-François Bruxelle, Séverine Péchiné & Anne Collignon. 2018. Updates on Clostridium difficile in Europe. Updates on Clostridium difficile in Europe
197
225
.
Fabio Antenucci, Cyrielle Fougeroux, Janine T. Bossé, Zofia Magnowska, Camille Roesch, Paul Langford, Peter Johannes Holst & Anders Miki Bojesen. (2017) Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae. Veterinary Research 48:1.
Crossref
Crossref
Mackenzie Henderson, Amanda Bragg, Germin Fahim, Monica Shah & Evelyn Hermes-DeSantis. (2017) A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections. Vaccines 5:3, pages 25.
Crossref
Crossref
Yi-Wen Liu, Yu-Hung Chen, Jenn-Wei Chen, Pei-Jane Tsai & I-Hsiu Huang. (2017) Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model. Frontiers in Microbiology 8.
Crossref
Crossref
Pingping Xing, Yanan Shi, Chuangchuang Dong, Hong Liu, Yan Cheng, Junbo Sun, Dalei Li, Min Li, Kaoxiang Sun & Dongxiao Feng. (2016) Colon-Targeted Delivery of IgY Against Clostridium difficile Toxin A and B by Encapsulation in Chitosan-Ca Pectinate Microbeads. AAPS PharmSciTech 18:4, pages 1095-1103.
Crossref
Crossref
Csaba Fehér, Alex Soriano & Josep Mensa. (2016) A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection. Infectious Diseases and Therapy 6:1, pages 1-35.
Crossref
Crossref
Anthony M. Buckley, Caitlin Jukes, Denise Candlish, June J. Irvine, Janice Spencer, Robert P. Fagan, Andrew J. Roe, John M. Christie, Neil F. Fairweather & Gillian R. Douce. (2016) Lighting Up Clostridium Difficile: Reporting Gene Expression Using Fluorescent Lov Domains. Scientific Reports 6:1.
Crossref
Crossref